In the CHB cohort, the univariate analysis (Model 3) identified the baseline PIVKA-II levels, AFP levels, and combined use of AFP and PIVKA-II levels score as significant predictors of HCC development. The gene discussed is AFP; the disease is hepatocellular carcinoma.